CDEK by Data4ThePeople
Sign in Sign up
← All drugs Report issue

ly3462817

mAbexperimental

Clinical trial activity

7 trials · 2 clinical orgs · 0 marketing orgs

Phase 1
4
Phase 2
3
Phase 3
0
Phase 4
0

Earliest trial started Dec 13, 2018 (NCT03715192)

Timeline

2010s

  1. Jan 1, 2018

    Earliest Phase 1 Sponsor(trial)

2020s

  1. Jan 1, 2020

    Earliest Phase 2 Sponsor(trial)

Indications

Studied for

Mechanism of action

Chemistry & pharmacology

Chirality
Single Stereoisomer
Inorganic
No
Polymer
No
Multi-specific
No

Oral

No

Parenteral

No

Topical

No

Sources

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT05959109Phase 1Jul 21, 2023Eli Lilly
NCT05516758Phase 2Aug 31, 2022Eli Lilly
NCT05440136Phase 1Jun 28, 2022Eli Lilly
NCT05193617Phase 2Jan 20, 2022Sun Yat-Sen University
NCT04634253Phase 2Dec 31, 2020Eli Lilly
NCT04152382Phase 1Nov 18, 2019Eli Lilly
NCT03715192Phase 1Dec 13, 2018Eli Lilly
Showing 7 of 7 trials
Page 1 / 1

Organizations

Research & Development (2)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Eli LillyFor profit6622018
Sun Yat-Sen UniversityAcademic/Hospital1112022
2 organizations
Page 1 / 1